menu
    • menu

    Company profile for Newron Pharmaceuticals

    NEW Drugs in Dev: 7
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s Partner Zambon. US World Meds holds the commercialization rights...
    Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s Partner Zambon. US World Meds holds the commercialization rights in the USA. Meiji Seika, in collaboration with Eisai, has the rights to develop and commercialize the compound in Japan and other key Asian territories.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Newron PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    89 Headquarters Plaza North - Suite 306 Morristown, NJ 07960
    Telephone
    Telephone
    +1 973 993 1873
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    https://www.linkedin.com/company/newron-pharmaceuticals-spa/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia
    Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia

    01 May 2026

    // BIOSPACE

    https://www.biospace.com/fda/patient-death-prompts-fda-pause-on-newrons-phase-3-schizophrenia-study

    BIOSPACE
    01 May 2026
    Share Share
    Newron Pauses ENIGMA-TRS 2 Study Enrollments at US Centers
    Newron Pauses ENIGMA-TRS 2 Study Enrollments at US Centers

    29 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7247894

    FIRSTWORD PHARMA
    29 Apr 2026
    Share Share
    Newron Presents 2025 Financial Results and Provides 2026 Outlook
    Newron Presents 2025 Financial Results and Provides 2026 Outlook

    24 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260324929483/en/Newron-Presents-2025-Financial-Results-and-Provides-2026-Outlook

    BUSINESSWIRE
    24 Mar 2026
    Share Share
    Newron to Present at 2026 SIRS Annual Congress
    Newron to Present at 2026 SIRS Annual Congress

    20 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260320454898/en/Newron-to-Present-at-the-2026-Annual-Congress-of-the-Schizophrenia-International-Research-Society-SIRS

    BUSSINESSWIRE
    20 Mar 2026
    Share Share
    Newron announces agreement with the European Investment Bank
    Newron announces agreement with the European Investment Bank

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/newron-announces-agreement-with-the-european-investment-bank-eib-to-extend-the-near-term-tranche-repayment-dates-of-its-2018-finance-contract

    PHARMIWEB
    19 Mar 2026
    Share Share
    Newron Announces Board Nominations at Upcoming AGM Meeting
    Newron Announces Board Nominations at Upcoming AGM Meeting

    18 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-18/newron-announces-nominations-to-its-board-of-directors-at-upcoming-annual-general-meeting

    PHARMIWEB
    18 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search